HHS: Paxlovid to be repackaged for appropriate dosing in kidney patients … Study: Some 40% of community-dwelling seniors are inadequately hydrated … “Bivalent” booster offers better protection...
Incidence of dementia varies widely by race and ethnicity in VA study
By
Alicia Lasek (f3)
Apr 21, 2022
The rate of dementia is significantly higher among seniors of some racial and ethnic groups enrolled with the U.S. Veterans Health Administration.
Seniors on common maintenance drugs face fewer COVID-19 risks, NIH study finds
By
Alicia Lasek
Apr 20, 2022
Drugs used regularly in the long-term care population may help prevent SARS-CoV-2 infection and poor COVID-19 outcomes, investigators say.
Study: Severity of injury — not age — predicts survival after brain trauma in seniors
By
Alicia Lasek
Apr 20, 2022
The oldest adults tended toward decreased mortality — and a subset of these patients had better-than-expected outcomes after falls and other incidents, investigators found.
U.S. lifespan on the rise while cardiovascular issues decline, long-term study finds
Apr 20, 2022
Better healthcare access and preventive measures have contributed to continued improvements in life expectancy and cardiovascular outcomes since the 1960s, investigators say.
Clinical briefs for Wednesday, April 20
By
Alicia Lasek
Apr 20, 2022
In-house CNA training program is one CCRC’s answer to workforce shortage … Cardiovascular mortality falls among dialysis patients … Alzheimer’s brain plaques linked to later psychiatric symptoms...
SNF physicians’ unique skill set requires more definition and support, industry docs say
By
Alicia Lasek
Apr 15, 2022
Insights into these doctors’ contributions and constraints are highlighted in interviews with medical directors and attending physicians.
Fourth dose of Pfizer vaccine renews protection against omicron in seniors, investigators find
By
Alicia Lasek
Apr 15, 2022
A fourth dose of Pfizer’s COVID-19 vaccine cuts the risk of infection and severe illness in older adults when compared to a third dose given months earlier, a new study from Israel finds.
Seniors with late-onset depression have poor treatment response
By
Alicia Lasek
Apr 15, 2022
About one fifth of the patients aged 65 and older with first-time depression did not respond to antidepressant treatment during a one-year study period.
Clinical briefs for Friday, April 15
By
Alicia Lasek
Apr 15, 2022
To boost or not to boost: Providers tackle the question … Exercise may protect against brain volume loss due to aging, investigators say … FDA delays REGEN-COV approval decision to July … U.S. economic...